Android Apple

Bicara Therapeutics, Adecoagro, and More Stocks See Action From Activist Investors

By MarketWatch   |   2 months ago
Bicara Therapeutics, Adecoagro, and More Stocks See Action From Activist Investors

RA Capital Management disclosed acquiring 6,955,993 shares of Bicara Therapeutics, a clinical-stage biopharmaceutical company, at $18 per share during its IPO on Sept. 16. This represents a 12.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.